YARROW BIOSCIENCE, INC. Number of Operating Segments
YARROW BIOSCIENCE, INC. (YARW) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. number of operating segments for the quarter ending 2019-03-31 was 1.00 Segment.
- YARROW BIOSCIENCE, INC. number of operating segments for fiscal 2019 was 1.00 Segment, a 0.00% change from fiscal 2018.
- YARROW BIOSCIENCE, INC. number of operating segments for fiscal 2018 was 1.00 Segment.
Segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2019-12-31 | 1.00 Segment 10-K · filed 2020-03-03 | |||
| 2019-09-30 | 1.00 Segment 10-Q · filed 2019-10-31 | |||
| 2019-06-30 | 1.00 Segment 10-Q · filed 2019-08-01 | |||
| 2019-03-31 | 1.00 Segment 10-Q · filed 2019-05-02 | |||
| 2018-12-31 | 1.00 Segment 10-K · filed 2019-02-28 | |||
| 2018-09-30 | 1.00 Segment 10-Q · filed 2018-11-07 | |||
| 2018-06-30 | 1.00 Segment 10-Q · filed 2018-08-01 |
segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 12 month |
|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | 1.00 segment S-4/A · filed 2026-06-03 | ||
| 2025-12-31 | 1.00 segment S-4/A · filed 2026-06-03 | ||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-08 | ||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-03-06 | ||
| 2017-12-31 | 1.00 segment 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |